These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 22924454)

  • 21. Comparison of Nine Instruments to Calculate Anticholinergic Load in a Large Cohort of Older Outpatients: Association with Cognitive and Functional Decline, Falls, and Use of Laxatives.
    Mayer T; Meid AD; Saum KU; Brenner H; Schöttker B; Seidling HM; Haefeli WE
    Am J Geriatr Psychiatry; 2017 May; 25(5):531-540. PubMed ID: 28233606
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum anticholinergic activity in a community-based sample of older adults: relationship with cognitive performance.
    Mulsant BH; Pollock BG; Kirshner M; Shen C; Dodge H; Ganguli M
    Arch Gen Psychiatry; 2003 Feb; 60(2):198-203. PubMed ID: 12578438
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Anticholinergic Drug Scale as a measure of drug-related anticholinergic burden: associations with serum anticholinergic activity.
    Carnahan RM; Lund BC; Perry PJ; Pollock BG; Culp KR
    J Clin Pharmacol; 2006 Dec; 46(12):1481-6. PubMed ID: 17101747
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of drugs with anticholinergic effect and impact on cognition in Parkinson's disease: a cohort study.
    Ehrt U; Broich K; Larsen JP; Ballard C; Aarsland D
    J Neurol Neurosurg Psychiatry; 2010 Feb; 81(2):160-5. PubMed ID: 19770163
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exploring the prevalence and variance of cognitive impairment, pain, neuropsychiatric symptoms and ADL dependency among persons living in nursing homes; a cross-sectional study.
    Björk S; Juthberg C; Lindkvist M; Wimo A; Sandman PO; Winblad B; Edvardsson D
    BMC Geriatr; 2016 Aug; 16(1):154. PubMed ID: 27549203
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Measures of anticholinergic drug exposure, serum anticholinergic activity, and all-cause postdischarge mortality in older hospitalized patients with hip fractures.
    Mangoni AA; van Munster BC; Woodman RJ; de Rooij SE
    Am J Geriatr Psychiatry; 2013 Aug; 21(8):785-93. PubMed ID: 23567395
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potential benefits of reducing medication-related anticholinergic burden for demented older adults: a prospective cohort study.
    Yeh YC; Liu CL; Peng LN; Lin MH; Chen LK
    Geriatr Gerontol Int; 2013 Jul; 13(3):694-700. PubMed ID: 23216534
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Delaying cognitive and physical decline through multidomain interventions for residents with mild-to-moderate dementia in dementia care units in Taiwan: A prospective cohort study.
    Liang CK; Chou MY; Chen LY; Wang KY; Lin SY; Chen LK; Lin YT; Liu TY; Loh CH
    Geriatr Gerontol Int; 2017 Apr; 17 Suppl 1():36-43. PubMed ID: 28436184
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between using medications with anticholinergic properties and short-term cognitive decline among older men: A retrospective cohort study in Taiwan.
    Wu YH; Wang CJ; Hung CH; Chen LY; Lin MH; Wang PN; Chen LK
    Geriatr Gerontol Int; 2017 Apr; 17 Suppl 1():57-64. PubMed ID: 28436193
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decrease of Anticholinergic Drug Use in Nursing Home Residents in the United States, 2009 to 2017.
    Malagaris I; Mehta HB; Li S; Goodwin JS
    J Am Geriatr Soc; 2020 Dec; 68(12):2797-2804. PubMed ID: 32798337
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug Burden Index and change in cognition over time in community-dwelling older men: the CHAMP study.
    Jamsen KM; Gnjidic D; Hilmer SN; Ilomäki J; Le Couteur DG; Blyth FM; Handelsman DJ; Naganathan V; Waite LM; Cumming RG; Bell JS
    Ann Med; 2017 Mar; 49(2):157-164. PubMed ID: 27763767
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drugs with anticholinergic properties and cognitive performance in the elderly: results from the PAQUID Study.
    Lechevallier-Michel N; Molimard M; Dartigues JF; Fabrigoule C; Fourrier-Réglat A
    Br J Clin Pharmacol; 2005 Feb; 59(2):143-51. PubMed ID: 15676035
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anticholinergic drugs and physical function among frail elderly population.
    Landi F; Russo A; Liperoti R; Cesari M; Barillaro C; Pahor M; Bernabei R; Onder G
    Clin Pharmacol Ther; 2007 Feb; 81(2):235-41. PubMed ID: 17192773
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anticholinergic exposure and cognitive decline in older adults: effect of anticholinergic exposure definitions in a 3-year analysis of the multidomain Alzheimer preventive trial (MAPT) study.
    Andre L; Gallini A; Montastruc F; Coley N; Montastruc JL; Vellas B; Andrieu S; Gardette V;
    Br J Clin Pharmacol; 2019 Jan; 85(1):71-99. PubMed ID: 30098049
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mobility and cognition at admission to the nursing home - a cross-sectional study.
    Sverdrup K; Bergh S; Selbæk G; Røen I; Kirkevold Ø; Tangen GG
    BMC Geriatr; 2018 Jan; 18(1):30. PubMed ID: 29378518
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increasing prevalence of anticholinergic medication use in older people in England over 20 years: cognitive function and ageing study I and II.
    Grossi CM; Richardson K; Savva GM; Fox C; Arthur A; Loke YK; Steel N; Brayne C; Matthews FE; Robinson L; Myint PK; Maidment ID
    BMC Geriatr; 2020 Jul; 20(1):267. PubMed ID: 32736640
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detailed cognitive function and use of drugs with anticholinergic properties in older people: a community-based cross-sectional study.
    Uusvaara J; Pitkala KH; Kautiainen H; Tilvis RS; Strandberg TE
    Drugs Aging; 2013 Mar; 30(3):177-82. PubMed ID: 23361527
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anticholinergic drug use, serum anticholinergic activity, and adverse drug events among older people: a population-based study.
    Lampela P; Lavikainen P; Garcia-Horsman JA; Bell JS; Huupponen R; Hartikainen S
    Drugs Aging; 2013 May; 30(5):321-30. PubMed ID: 23475596
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of anticholinergic burden in primary care patients with first cognitive complaints.
    Grande G; Tramacere I; Vetrano DL; Clerici F; Pomati S; Mariani C; Filippini G;
    Eur J Neurol; 2017 Jul; 24(7):950-955. PubMed ID: 28503836
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anticholinergic medication use and cognitive impairment in the older population: the medical research council cognitive function and ageing study.
    Fox C; Richardson K; Maidment ID; Savva GM; Matthews FE; Smithard D; Coulton S; Katona C; Boustani MA; Brayne C
    J Am Geriatr Soc; 2011 Aug; 59(8):1477-83. PubMed ID: 21707557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.